-+ 0.00%
-+ 0.00%
-+ 0.00%

Bioretec names Conan Cavanagh as R&D chief, executive team member

PUBT·06/17/2026 13:01:15
Listen to the news
Bioretec names Conan Cavanagh as R&D chief, executive team member
  • Bioretec appointed Conan Cavanagh as chief R&D officer, effective Sept. 1, 2026.
  • Cavanagh joins the management team, reporting to CEO Sarah van Hellenberg Hubar-Fisher.
  • He is currently COO and head of R&D at HidraMed Solutions.
  • Previous roles include engineering director at Smith & Nephew, overseeing orthopedic and sports medicine development and commercialization.
  • Mandate covers R&D strategy, portfolio leadership, product development execution, clinical evidence, readiness, long-term growth support.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioretec Oyj published the original content used to generate this news brief via Cision (Ref. ID: 202606170900BITN____UKPR__FI_20260617-BIT-8995-0) on June 17, 2026, and is solely responsible for the information contained therein.